glp 1 shot weight loss Effective GLP-1 The FDA has approved the

As the worlds largest and most influential conference in the field of diabetes and metabolic diseases, the event brought together leading pharmaceutical companies and research institutions to showcase the latest clinical progress in innovative metabolic therapies

Export PDF Generate clean reports to share with your care team

Whether you are considering your first weight loss medication, switching from phentermine to something stronger, or trying to understand why your doctor recommended one over the other, the comparison that follows will give you specific numbers and evidence to make a genuinely informed decision

Redness, swelling, or itching at the injection site can occur

April 18, 2026 Drugs Consultative Committee 68th meeting flags surrogate advertising of GLP-1 obesity drugs state regulators directed to enforce Medical Dialogues March 24, 2026 CDSCO tightens checks on generic semaglutide bans promotional activity, intensifies pharmacy surveillance Business Standard March 21, 2026 Patent expiry Day 1 8+ manufacturers launch simultaneously, prices fall up to 90% from branded versions CNBC March 17, 2026 ZydusLupin and ZydusTorrent licensing agreements announced ahead of patent expiry Pearce IP February 2026 Natco Pharma receives CDSCO approval for generic semaglutide Eris Lifesciences to commercialise Fierce Pharma December 2025 Sun Pharma receives first DCGI approval for generic semaglutide in India Noveltreat and Sematrinity Sun Pharma PR REGULATORY FRAMEWORK CDSCO Standards & Approval Requirements in India India's Central Drugs Standard Control Organisation (CDSCO) is the national drug regulator equivalent to the US FDA